Premium
Meta‐analysis finds small benefit for quetiapine in schizophrenia
Publication year - 2015
Publication title -
the brown university psychopharmacology update
Language(s) - English
Resource type - Journals
eISSN - 1556-7532
pISSN - 1068-5308
DOI - 10.1002/pu.30069
Subject(s) - quetiapine , schizophrenia (object oriented programming) , meta analysis , sedation , adverse effect , medicine , antipsychotic , quetiapine fumarate , antipsychotic drug , psychiatry , psychology , atypical antipsychotic , anesthesia , pharmacology
A systematic review and meta‐analysis has concluded that the immediate‐release formulation of the antipsychotic quetiapine has a small beneficial effect on overall symptoms of schizophrenia. The review found no evidence of increased risk of serious adverse events but did indicate that the drug generates a moderate to large effect on weight gain and also leads to sedation in a significant number of cases.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom